Abbott Surpasses Expectations in Q2 | Business and Finance News

Abbott Labs just smashed Q2 2026 earnings, posting $12.59 billion in revenue—a 13% surge year-over-year—and topping profit forecasts. The company also raised its full-year outlook, signaling strong momentum. With a legacy dating back to 1888 and a diverse portfolio from medical devices to nutritionals, Abbott continues to show resilience. While profit margins dipped slightly due to rising costs, the overall growth trend remains encouraging. Wall Street is already betting on even stronger gains ahead, and the stock jumped after results. Investors should keep an eye on long-term fundamentals, but this quarter’s top-line strength is a solid win. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/509f84617596f0b1